The DIA Annual Meeting 2026 brought together pharmaceutical, biotechnology, regulatory, and healthcare professionals from across the global life sciences community, providing a valuable setting for PharmaKnowl Consulting to connect with industry stakeholders and exchange perspectives on the evolving healthcare landscape.

Across the two-day event, the PharmaKnowl team welcomed visitors at the exhibition booth, engaging in conversations with professionals and organizations interested in the Saudi pharmaceutical and healthcare market. These discussions covered a range of topics related to entering and operating within Saudi Arabia, as well as the regulatory and market considerations that companies need to navigate.

The event provided an opportunity to showcase PharmaKnowl’s expertise across Saudi regulatory affairs, pharmacovigilance, clinical research, and market access, while gaining a deeper understanding of the priorities and challenges faced by international life sciences companies exploring opportunities in the region.

From one-to-one discussions at the booth to conversations with professionals from different markets and areas of expertise, the meeting created opportunities to build new connections and strengthen existing relationships within the global life sciences community.

For PharmaKnowl, events such as DIA Annual Meeting provide an important platform for connecting Saudi regulatory expertise with international pharmaceutical, biotechnology, and healthcare organizations. The conversations held throughout the event also highlighted the continued interest in Saudi Arabia as a market for innovative medicines, healthcare products, and life sciences investment.